You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《港股開市》恆指低開31點 藥明生物挫近15%
美股昨(7日)個別發展,標普500指數及納指受Meta Platforms股價下挫拖累走軟。港股早市偏軟。恆指低開31點或0.13%,報24,548點;國指低開5點或0.07%,報8,583點;恆生科技指數低開32點或0.58%,報5,497點。 美商務部將33家中國企業加入未覈實清單,包括藥明生物(02269.HK)附屬及中車集團旗下株洲中車特種裝備科技等。藥明生物低開14.8%報68.7元,中車則高開0.3%報3.7元。 科技股方面,騰訊(00700.HK)低開0.7%報474.6元,阿裏巴巴(09988.HK)低開2.1%報112.6元,小米(01810.HK)及美團(03690.HK)各低開0.2%及0.1%,京東(09618.HK)低開1.4%報288元。 金融股匯控(00005.HK)高開1%報58.5元,港交所(00388.HK)低開0.1%報445元,友邦(01299.HK)高開2.3%報87元。內房股仍造好。潤地(01109.HK)高開1.2%。內險股中國平安(02318.HK)高開1.3%。出口股創科(00669.HK)高開2.2%。 九尊數字互娛(01961.HK)71.9%股權轉手觸發技術性全面收購,股價復牌急升30.3%報0.99元。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account